Since TSA may induce apoptosis in certain tumor cells through a caspase-3 and mitochondria dependent pathway [46], it is possible that TSA-treated apoptotic B16 cells release bioactive lipids, which promote innate, perhaps TLR and NK mediated, immunity as well as adaptive responses. The gene discussed is CASP3; the disease is neoplasm.